Jiaming Yang
5 Papers
12 Citations
Jiaming Yang is an academic researcher. The author has contributed to research in topics: Vaccination & Immunity. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance.
Xuezhi Cao,Yong Liang,Zhenxiang Hu,Huiyu Li,Jiaming Yang,Eric Hsu,Jiankun Zhu,Jin Zhou,Yang Xin Fu +8 more
TL;DR: In this article, a masked type I interferon-Fc (ProIFN) with its natural receptor connected by a cleavable linker that can be targeted by tumorassociated proteases was proposed.
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
Shiyu Sun,Yueqi Cai,Tian-Zhang Song,Yang Pu,Lin Cheng,Hairong Xu,Chaoyang Meng,Yifan Lin,Jin Sun,Silin Zhang,Yu Gao,Jian-Bao Han,Xiao-Li Feng,Dan-Dan Yu,Yalan Zhu,Pu Gao,Haidong Tang,Jincun Zhao,Jiaming Yang,Zenxiang Hu,Zheng Zhang,Yang Xin Fu,Yong-Tang Zheng,Hua Peng +23 more
TL;DR: In this article, an interferon-armed RBD dimerized by immunoglobulin fragment (I-R-F) was developed to enhance antigen processing and cross-presentation in draining lymph nodes (DLNs).
6
Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.
Shiyu Sun,Yueqi Cai,Tian-Zhang Song,Yang Pu,Lin Cheng,Hairong Xu,Jing Sun,Chaoyang Meng,Yifan Lin,Haibin Huang,Fang Zhao,Silin Zhang,Yu Gao,Jian-Bao Han,Xiao-Li Feng,Dan-Dan Yu,Yalan Zhu,Pu Gao,Haidong Tang,Jincun Zhao,Zheng Zhang,Jiaming Yang,Zhenxiang Hu,Yang Xin Fu,Yong-Tang Zheng,Hua Peng +25 more
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.
Shiyu Sun,Yueqi Cai,Tian-Zhang Song,Yang Pu,Lin Cheng,Hairong Xu,Jing Sun,Chaoyang Meng,Yifan Lin,Haibin Huang,Fang Zhao,Silin Zhang,Yu Gao,Jian-Bao Han,Xiao-Li Feng,Dan-Dan Yu,Yalan Zhu,Pu Gao,Haidong Tang,Jincun Zhao,Zheng Zhang,Jiaming Yang,Zhenxiang Hu,Yang Xin Fu,Yong-Tang Zheng,Hua Peng +25 more
TL;DR: In this article, an interferon-armed RBD dimerized by an immunoglobulin fragment (I-R-F) was developed to enhance antigen processing and cross-presentation in draining lymph nodes (DLNs).